Induction of gamma-interferon by avarol in human peripheral blood lymphocytes. 1988

R Voth, and S Rossol, and G Hess, and H P Laubenstein, and K H Meyer zum Büschenfelde, and H C Schröder, and M Bachmann, and P Reuter, and W E Müller
I. Medizinische Klinik und Poliklinik, Universität, Mainz, West Germany.

Avarol is a cytostatic and anti-human immunodeficiency virus (HIV) agent. In this study, the avarol caused induction of gamma-interferon (IFN-gamma) in buffy coat cells (human peripheral blood lymphocytes) is demonstrated by immunological and molecular biological techniques. IFN-gamma production was detected after a 24-hr incubation period with avarol; maximal production was obtained after 5 days in the presence of the optimal avarol concentration of 0.75 microgram/ml. Blotting experiments using human IFN-gamma cDNA and beta-actin cDNA containing plasmids showed that in the absence of avarol no IFN-gamma transcripts were present in lymphocytes. Already after a 24-hr incubation with avarol, IFN-gamma gene induction was detected, and maximal induction was found after a 5-day incubation period. The enhanced IFN-gamma production seems to be caused by a change at the transcriptional and/or post-transcriptional level, but not during subsequent nucleocytoplasmic transport of mRNA. This molecular event is specific, at least in relation to the expression of the beta-actin gene. Our studies demonstrate that avarol displays, besides its potential anti-tumor and anti-HIV activity, a potential immunomodulating effect.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012717 Sesquiterpenes Fifteen-carbon compounds formed from three isoprenoid units with general formula C15H24. Farnesanes,Farnesene,Farnesenes,Sesquiterpene,Sesquiterpene Derivatives,Sesquiterpenoid,Sesquiterpenoids,Derivatives, Sesquiterpene
D015533 Transcriptional Activation Processes that stimulate the GENETIC TRANSCRIPTION of a gene or set of genes. Gene Activation,Genetic Induction,Transactivation,Induction, Genetic,Trans-Activation, Genetic,Transcription Activation,Activation, Gene,Activation, Transcription,Activation, Transcriptional,Genetic Trans-Activation,Trans Activation, Genetic

Related Publications

R Voth, and S Rossol, and G Hess, and H P Laubenstein, and K H Meyer zum Büschenfelde, and H C Schröder, and M Bachmann, and P Reuter, and W E Müller
May 1992, Journal of studies on alcohol,
R Voth, and S Rossol, and G Hess, and H P Laubenstein, and K H Meyer zum Büschenfelde, and H C Schröder, and M Bachmann, and P Reuter, and W E Müller
February 1982, Infection and immunity,
R Voth, and S Rossol, and G Hess, and H P Laubenstein, and K H Meyer zum Büschenfelde, and H C Schröder, and M Bachmann, and P Reuter, and W E Müller
March 1984, Nagoya journal of medical science,
R Voth, and S Rossol, and G Hess, and H P Laubenstein, and K H Meyer zum Büschenfelde, and H C Schröder, and M Bachmann, and P Reuter, and W E Müller
January 2003, American journal of physiology. Cell physiology,
R Voth, and S Rossol, and G Hess, and H P Laubenstein, and K H Meyer zum Büschenfelde, and H C Schröder, and M Bachmann, and P Reuter, and W E Müller
September 1989, The Journal of experimental medicine,
R Voth, and S Rossol, and G Hess, and H P Laubenstein, and K H Meyer zum Büschenfelde, and H C Schröder, and M Bachmann, and P Reuter, and W E Müller
January 1989, Immunopharmacology,
R Voth, and S Rossol, and G Hess, and H P Laubenstein, and K H Meyer zum Büschenfelde, and H C Schröder, and M Bachmann, and P Reuter, and W E Müller
May 1987, Proceedings of the National Academy of Sciences of the United States of America,
R Voth, and S Rossol, and G Hess, and H P Laubenstein, and K H Meyer zum Büschenfelde, and H C Schröder, and M Bachmann, and P Reuter, and W E Müller
June 1989, Journal of biochemistry,
R Voth, and S Rossol, and G Hess, and H P Laubenstein, and K H Meyer zum Büschenfelde, and H C Schröder, and M Bachmann, and P Reuter, and W E Müller
January 1981, Microbiology and immunology,
R Voth, and S Rossol, and G Hess, and H P Laubenstein, and K H Meyer zum Büschenfelde, and H C Schröder, and M Bachmann, and P Reuter, and W E Müller
June 1986, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!